Remolta, Ailyn A.

HRN: 28-51-17  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/01/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/01/2026
02/08/2026
IVT
600mg
Q6
Infected Wound Left Breast
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: